Literature DB >> 9840227

Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release.

E S Vizi1.   

Abstract

The temperature dependence of transmitter release associated with axonal conduction, evoked by ligand-gated mechanism and by reversed operation of plasma membrane transporter was studied in superfused slice preparation. When the temperature was reduced from 37-17 degrees C the release of [3H]noradrenaline ([3H]NA) and [3H]dopamine ([3H]DA) in response to field stimulation was significantly enhanced in slice preparations of the hippocampus and main olfactory bulbs. The release of [3H]dopamine evoked by a ligand-gated mechanism (nicotine receptor stimulation) was potentiated at low temperature (12 degrees C). In contrast, when transmitter release was evoked by ouabain, a drug inhibiting Na+/K+-activated ATPase and thereby increasing [Na+]i the release of [3H]GABA was enhanced. This release was very sensitive to cooling (Q10=3.5 between 37 degrees C and 27 degrees C), indicating that the release was induced by a reversed operation of the transporter. The excessive release of [3H]NA from the hippocampal slice in response to oxygen and glucose deprivation (simulation of ischemia) was also inhibited in a temperature-dependent manner. Because at low temperatures (17-12 degrees C) only one type of release mechanism (exocytosis) is operational and carrier-mediated uptake and release is inhibited, this temperature condition provides a method to study the mode of action of different drugs (e.g. amphetamine) and the effect(s) of certain conditions (e.g. ischemia) on the mechanisms of transmitter release, specifically whether they exert their transmitter releasing effect through an exocytotic process or through the reversed operation of plasma membrane transporter. This finding also suggests that it would be important to re-examine mechanistic conclusions based on results from electrophysiological, neurochemical and pharmacological studies that have been carried out at room temperature (approximately 20 degrees C). In particular because transmitter release associated with the action potential, diffusion, receptor kinetics, active transport in both directions (uptake and release) and the probability of transmitter release are all temperature dependent, it would seem important to carry out experiments involving these processes at physiological temperature (37 degrees C).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840227     DOI: 10.1016/s0197-0186(98)00040-0

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  15 in total

1.  Distinct mechanisms underlying alpha1-adrenoceptor and P2x purinoceptor operated ATP release and contraction in the guinea-pig vas deferens.

Authors:  B Sperlágh; P Illes; Z Gerevich; A Köfalvi
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 2.  Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function.

Authors:  D Lichtstein; H Rosen
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

3.  Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.

Authors:  I Katona; B Sperlágh; A Sík; A Käfalvi; E S Vizi; K Mackie; T F Freund
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

4.  The effects of volatile anesthetics on the extracellular accumulation of [(3)H]GABA in rat brain cortical slices.

Authors:  Paulo H C Diniz; Cristina Guatimosim; Nancy S Binda; Flávia L P Costa; Marcus V Gomez; Renato S Gomez
Journal:  Cell Mol Neurobiol       Date:  2013-10-01       Impact factor: 5.046

Review 5.  Physiological fluctuations in brain temperature as a factor affecting electrochemical evaluations of extracellular glutamate and glucose in behavioral experiments.

Authors:  Eugene A Kiyatkin; Ken T Wakabayashi; Magalie Lenoir
Journal:  ACS Chem Neurosci       Date:  2013-03-14       Impact factor: 4.418

6.  The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells.

Authors:  T Zelles; L Franklin; I Koncz; B Lendvai; G Zsilla
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

7.  Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+ -ATPase inhibitor.

Authors:  M G Bersier; V Miksztowicz; C Peña; G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

8.  The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes.

Authors:  Seth D Norrholm; David B Horton; Linda P Dwoskin
Journal:  Neuropharmacology       Date:  2007-10-07       Impact factor: 5.250

9.  Some Operational Characteristics of Glycine Release in Rat Retina: The Role of Reverse Mode Operation of Glycine Transporter Type-1 (GlyT-1) in Ischemic Conditions.

Authors:  Adrienn Hanuska; Gábor Szénási; Mihaly Albert; Laszlo Koles; Agoston Varga; Andras Szabo; Peter Matyus; Laszlo G Harsing
Journal:  Neurochem Res       Date:  2015-09-12       Impact factor: 3.996

10.  Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices.

Authors:  Paulo H C Diniz; Janice H Silva; Marcus V Gomez; Cristina Guatimosim; Renato S Gomez
Journal:  Cell Mol Neurobiol       Date:  2007-08-07       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.